skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I know you liked this company in your last update.Since then the company has reported their first quarter results.The stock has been performing very well recently and has appeared to have broken out technically. Can you provide your latest thoughts on this company and has your opinion become more favorable to taking an initial position.
Thanks as always for your wonderful insights!
Read Answer Asked by Thomas on May 29, 2017
Q: Hi 5i team,

LULU has really taken a beating these past two weeks despite strong financials, solid management, and the majority of analysts believing it will outperform the market. I am down quite a bit recently, and I was wondering if I should keep purchasing the shares as they continue to decrease in value with the hopes of a rebound?

For Sleep Country, do you also believe that this is a hold despite the drop in price that occurred in the past two weeks?

Thanks as always for your excellent advice!
Read Answer Asked by Hillary on May 29, 2017
Q: I am up nicely with this stock your thoughts please thanks bill
Read Answer Asked by William on May 25, 2017
Q: Just a follow up to an earlier question on May 8. Your answer to a question regarding ZCL was "selling such a large portion so close to the quarter end does not 'look' good in hindsight with the bad quarter. We will attempt to get clarity here,". I was wondering if enough time has passed for the team to get any clarity on insider's selling during a bad quarter. ZCL has been one I've been thinking of adding to but am hesitant with recent results.
Thanks for all your advise. Craig
Read Answer Asked by Craig on May 19, 2017
Q: Hi Team, On May 8/17 I asked a general question on TOS and your answer was:TOS has done a very good job getting the company to where it is, with FDA approval, good partners and a solid growth opportunity worldwide. We like what it has done, and it has good potential. But.....the stock is very expensive and this needs consideration. It trades at 7X 'expected' 2018 sales already. It is expected to turn a profit in 2018 but any slowdown or problems would really hurt the stock. We would not 'assume' 40% returns here, but do like it generally today.
I have a followup question, how much of TOS's revenue would come from the US or Europe? My thinking is if TOS has a significant exposure to the US in particular this would help me make an investment decision. It appears to me today good companies with US exposure are worth a little special attention or premium. Thanks as always. Chris
Read Answer Asked by Chris on May 17, 2017
Q: I bought this stock earlier this week en route to emulate your Growth portfolio in my TFSA. I currently hold a 1.6% position. The stock dropped 7% in 2 days,is that the normal volatility for this stock or there is something to be concerned about? Does this drop become an opportunity to take a full position (~5%) as per you portfolio allocation. Thanks for you insight
Read Answer Asked by Francois on May 09, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!